FMP
Regencell Bioscience Holdings Limited
RGC
NASDAQ
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
12.62 USD
-1.47 (-11.65%)
Historical Prices
From:
To:
About
ceo
Mr. Yat-Gai Au
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
exchange
NASDAQ
Description
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
CIK
0001829667
ISIN
KYG7487R1002
CUSIP
G7487R100
Address
First Commercial Building
Phone
852 2155 0823
Country
HK
Employee
12
IPO Date
Jul 16, 2021
Financial Statement
Earnings
RGC Financial Summary
CIK
0001829667
Exchange
NASDAQ
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
G7487R100
ISIN
KYG7487R1002
Country
HK
Price
12.62
Beta
-0.62
Volume Avg.
494.17k
Market Cap
164.22M
Shares
-
52-Week
3.03-32.44
DCF
0.23
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-38.24
P/B
-
Website
https://www.regencellbioscience.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest RGC News
Rayan Ahmad
3 days ago
Recent Market Trends and Notable Price Changes in Companies
In recent market trends, several companies have shown notable price changes, reflecting various factors driving investor interest. On NASDAQ, Regencell Bioscience Holdings Limited (RGC) saw its price jump to $9.8, a 133.33% increase. This surge is likely due to breakthroughs or positive developments in its research on ADHD and autism spectrum disorder treatments, as highlighted by its significant trading volume of 15,951,916. Ainos, Inc. (AIMDW) experienced a 122.875% price rise to $0.1783, wit...
Benzinga
May 18, 2022
Sector Rotation And 9 Stocks To Watch During A Recession
Is the United States heading toward a recession? This has been the looming question on the minds of Americans since inflation topped at 8.5% in March, matched with other indicators such as rising interest rates and the bond market's inverted yield curve.
Benzinga
Feb 17, 2022
Regencell Bioscience's COVID-19 Candidate Shows Encouraging ...
Regencell Bioscience Holdings Limited (NASDAQ: RGC) announced the results from the EARTH efficacy trial of its COVID-19 candidate. RGC-COV19 (Regencell Bioscience (RGCA-CV01) liquid formulation) is an oral TCM candidate.
Benzinga
Sep 2, 2021
Regencell Bioscience Stock Jumps On Formation Of COVID-19 Tr...
Regencell Bioscience Holdings Ltd's (NASDAQ: RGC) subsidiary in Hong Kong has entered into a joint venture agreement with Honor Epic Enterprises Limited to offer COVID-19 related treatments. The joint venture will cater to patients in ASEAN countries, India, Japan, Australia, and New Zealand.
Pulse2
Aug 25, 2021
RGC Stock: Over 40% Pre-Market Details
The stock price of Regencell Bioscience Holdings Ltd (NASDAQ: RGC) increased by over 40% pre-market. This is why it happened.
Pulse2
Aug 22, 2021
Regencell Bioscience Shares Increased 204.13%: Why It Happen...
The shares of Regencell Bioscience Holdings Ltd (NASDAQ: RGC) increased 204.13% in the previous trading session on August 20. This is why it happened.
PennyStocks
Aug 20, 2021
Is RGC Stock Rallying On Mistaken Identity?
Will RGC Stock Crash Or Go Higher After Today? The post Is RGC Stock Rallying On Mistaken Identity?
Business Wire
Aug 20, 2021
Regencell Bioscience Holdings Limited Announces Partial Exer...
HONG KONG--(BUSINESS WIRE)--Regencell Bioscience Holdings Limited (NASDAQ:RGC) ("Regencell" or the "Company"), an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine ("TCM") for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder ("ADHD") and Autism Spectrum Disorder ("ASD"), today announced that the underwriter of its initial public offering (the “Offering”) had
